Tumor

Use of an augmented reality-assisted pedicle screw navigation system may be a reliable and safe tool for patients undergoing spine surgery, according to published results.

Individuals recently diagnosed with cancer frequently decide on their own to visit hospital emergency departments for symptoms that do not require immediate care, according to a study conducted at UT Southwestern Medical Center.

A Boston-area biopharmaceutical has announced additional positive biomarker data from a phase 1/2a study of a novel cancer vaccine immunotherapeutic intended to treat those with recurrent glioblastoma.

Precision oncology therapies requiring biomarker testing comprised 43% of all FDA oncology drug approvals between 1998 and 2022, study results published in Cancer Discovery showed.

In this video, Nour Abdallah, MD, discusses an abstract presented at American Urological Association Annual Meeting that investigated tumor contact surface area score and the potential use of artificial intelligence models in kidney cancer.

Knowledge, expectations and attitudes of patients with cancer about genomic tumor testing appeared to be associated with their respective education and income levels, according to a study published in JCO Precision Oncology.

Belzupacap sarotalocan via suprachoroidal administration demonstrated positive interim phase 2 safety and efficacy data at an average of 9 months follow-up for the treatment of early-stage choroidal melanoma.

Black women with ER-positive, early-stage breast cancer appeared at significantly higher risk for death than their white counterparts, according to study results published in JAMA Oncology.

Tumor invasion beyond the subcutaneous fat, along with perineural invasion, were associated with poor outcomes in primary cutaneous squamous cell carcinoma, according to a study.